US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis - Editorial response

被引：42

作者：

Berman, JD ^{[1
]}

机构：

[1] Walter Reed Army Med Ctr, Walter Reed Army Inst Res, Div Expt Therapeut, Washington, DC 20307 USA

来源：

CLINICAL INFECTIOUS DISEASES | 1999年 / 28卷 / 01期

关键词：

D O I：

10.1086/515086

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：49 / 51

页数：3

共 11 条

[1]

Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25

[2] Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years [J].

Berman, JD .

CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :684-703

[3] Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome) [J].

Davidson, RN ;

diMartino, L ;

Gradoni, L ;

Giacchino, R ;

Gaeta, GB ;

Pempinello, R ;

Scotti, S ;

Cascio, A ;

Castagnola, E ;

Maisto, A ;

Gramiccia, M ;

diCaprio, D ;

Wilkinson, RJ ;

Bryceson, ADM .

CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) :938-943

[4]

DAVIDSON RN, 1994, Q J MED, V87, P75

[5] Leishmaniasis - Public health aspects and control [J].

Desjeux, P .

CLINICS IN DERMATOLOGY, 1996, 14 (05) :417-423

[6] TREATMENT OF BRAZILIAN KALA-AZAR WITH A SHORT-COURSE OF AMPHOCIL (AMPHOTERICIN-B CHOLESTEROL DISPERSION) [J].

DIETZE, R ;

MILAN, EP ;

BERMAN, JD ;

GROGL, M ;

FALQUETO, A ;

FEITOSA, TF ;

LUZ, KG ;

SUASSUNA, FAB ;

MARINHO, LAC ;

KSIONSKI, G .

CLINICAL INFECTIOUS DISEASES, 1993, 17 (06) :981-986

[7] Randomised controlled trial of aminosidine (paromomycin) υ sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India [J].

Jha, TK ;

Olliaro, P ;

Thakur, CPN ;

Kanyok, TP ;

Singhania, BL ;

Singh, IJ ;

Singh, NKP ;

Akhoury, S ;

Jha, S .

BRITISH MEDICAL JOURNAL, 1998, 316 (7139) :1200-1205

[8] US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis [J].

Meyerhoff, A .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (01) :42-48

[9] Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony [J].

Sundar, S ;

Agrawal, NK ;

Sinha, PR ;

Horwith, GS ;

Murray, HW .

ANNALS OF INTERNAL MEDICINE, 1997, 127 (02) :133-137

[10] Comparison of three treatment regimens with liposomal amphotericin B (AmBisome(R)) for visceral leishmaniasis in India: A randomized dose-finding study [J].

Thakur, CP ;

Pandey, AK ;

Sinha, GP ;

Roy, S ;

Behbehani, K ;

Olliaro, P .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (03) :319-322

← 1 2 →